CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis
USA - NASDAQ:CCRN - US2274831047 - Common Stock
12.37 USD
-0.67 (-5.14%)
12.37 USD
0 (0%)
Overall CCRN gets a fundamental rating of 5 out of 10. We evaluated CCRN against 100 industry peers in the Health Care Providers & Services industry. While CCRN has a great health rating, its profitability is only average at the moment. CCRN is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CCRN had positive earnings in the past year.
In the past year CCRN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CCRN reported negative net income in multiple years.
Of the past 5 years CCRN 4 years had a positive operating cash flow.
1.2 Ratios
CCRN has a Return On Assets (-1.51%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -2.02%, CCRN is in line with its industry, outperforming 51.00% of the companies in the same industry.
CCRN's Return On Invested Capital of 1.44% is in line compared to the rest of the industry. CCRN outperforms 41.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CCRN is significantly above the industry average of 9.42%.
The 3 year average ROIC (15.05%) for CCRN is well above the current ROIC(1.44%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.51% | ||
| ROE | -2.02% | ||
| ROIC | 1.44% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
With a Operating Margin value of 0.78%, CCRN perfoms like the industry average, outperforming 41.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CCRN has declined.
CCRN has a Gross Margin (20.19%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CCRN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.78% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
CCRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CCRN has less shares outstanding
The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 5.01 indicates that CCRN is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.01, CCRN belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 5.01 |
ROIC/WACC0.16
WACC9.11%
2.3 Liquidity
A Current Ratio of 3.21 indicates that CCRN has no problem at all paying its short term obligations.
The Current ratio of CCRN (3.21) is better than 85.00% of its industry peers.
CCRN has a Quick Ratio of 3.21. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CCRN (3.21) is better than 86.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.21 | ||
| Quick Ratio | 3.21 |
3. Growth
3.1 Past
CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -78.35%.
The Earnings Per Share has been growing by 24.57% on average over the past years. This is a very strong growth
CCRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.30%.
The Revenue has been growing by 10.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-78.35%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-110%
Revenue 1Y (TTM)-24.3%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-19.34%
3.2 Future
Based on estimates for the next years, CCRN will show a very negative growth in Earnings Per Share. The EPS will decrease by -16.16% on average per year.
CCRN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.63% yearly.
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 58.90, CCRN can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as CCRN.
When comparing the Price/Earnings ratio of CCRN to the average of the S&P500 Index (25.83), we can say CCRN is valued expensively.
CCRN is valuated quite expensively with a Price/Forward Earnings ratio of 47.10.
The rest of the industry has a similar Price/Forward Earnings ratio as CCRN.
When comparing the Price/Forward Earnings ratio of CCRN to the average of the S&P500 Index (32.68), we can say CCRN is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.9 | ||
| Fwd PE | 47.1 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CCRN is valued a bit cheaper than the industry average as 62.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CCRN is valued cheaper than 81.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.89 | ||
| EV/EBITDA | 12.79 |
4.3 Compensation for Growth
A cheap valuation may be justified as CCRN's earnings are expected to decrease with -16.16% in the coming years.
PEG (NY)N/A
PEG (5Y)2.4
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
5. Dividend
5.1 Amount
No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
12.37
-0.67 (-5.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.83%
Inst Owner Change-1.24%
Ins Owners5.37%
Ins Owner Change-0.41%
Market Cap405.24M
Revenue(TTM)1.19B
Net Income(TTM)-8.35M
Analysts52.31
Price Target18.44 (49.07%)
Short Float %8.73%
Short Ratio7.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-56.4%
Min EPS beat(2)-118.38%
Max EPS beat(2)5.59%
EPS beat(4)2
Avg EPS beat(4)-39.17%
Min EPS beat(4)-118.38%
Max EPS beat(4)22.23%
EPS beat(8)4
Avg EPS beat(8)-22%
EPS beat(12)8
Avg EPS beat(12)-10.41%
EPS beat(16)12
Avg EPS beat(16)-0.77%
Revenue beat(2)0
Avg Revenue beat(2)-6.65%
Min Revenue beat(2)-7.46%
Max Revenue beat(2)-5.84%
Revenue beat(4)0
Avg Revenue beat(4)-3.61%
Min Revenue beat(4)-7.46%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-2.19%
Revenue beat(12)4
Avg Revenue beat(12)-0.89%
Revenue beat(16)7
Avg Revenue beat(16)0.6%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-42.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 58.9 | ||
| Fwd PE | 47.1 | ||
| P/S | 0.34 | ||
| P/FCF | 11.89 | ||
| P/OCF | 9.74 | ||
| P/B | 0.98 | ||
| P/tB | 1.69 | ||
| EV/EBITDA | 12.79 |
EPS(TTM)0.21
EY1.7%
EPS(NY)0.26
Fwd EY2.12%
FCF(TTM)1.04
FCFY8.41%
OCF(TTM)1.27
OCFY10.27%
SpS36.4
BVpS12.58
TBVpS7.31
PEG (NY)N/A
PEG (5Y)2.4
Graham Number7.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.51% | ||
| ROE | -2.02% | ||
| ROCE | 2.04% | ||
| ROIC | 1.44% | ||
| ROICexc | 1.75% | ||
| ROICexgc | 3.24% | ||
| OM | 0.78% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% | ||
| FCFM | 2.86% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 42.39% | ||
| Cap/Sales | 0.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.74% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.21 | ||
| Quick Ratio | 3.21 | ||
| Altman-Z | 5.01 |
F-Score5
WACC9.11%
ROIC/WACC0.16
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.35%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-110%
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.3%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-19.34%
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
EBIT growth 1Y-69.02%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year540.8%
EBIT Next 3Y89.71%
EBIT Next 5YN/A
FCF growth 1Y-88.57%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-86.63%
OCF growth 3YN/A
OCF growth 5Y85.29%
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCRN.
Can you provide the valuation status for CROSS COUNTRY HEALTHCARE INC?
ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.
Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.
What is the financial health of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
The financial health rating of CROSS COUNTRY HEALTHCARE INC (CCRN) is 10 / 10.